0001505497
EX-FILING FEES
0001505497
2025-11-18
2025-11-18
0001505497
1
2025-11-18
2025-11-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
EXHIBIT
107
Calculation
of Filing Fee Tables
FORM
S-1
(Form
Type)
BIORESTORATIVE
THERAPIES, INC.
(Exact
Name of Registrant as Specified in its Charter)
Table
1: Newly Registered Securities and Carry Forward Securities
| | | |
Security
Type | |
Security
Class Title | |
Fee
Calculation or Carry Forward Rule | | |
Amount
Registered | | |
Proposed
Maximum Offering Price Per Share | | |
Maximum
Aggregate Offering Price | | |
Fee
Rate | | |
Amount
of Registration Fee | | |
Carry
Forward Form Type | | |
Carry
Forward File Number | | |
Carry
Forward Initial Effective Date | | |
Filing
Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |
| Newly
Registered Securities | |
Fees
to Be Paid | | |
Equity | |
Common
Stock, par value $0.0001 per share | |
| 457 (o) | | |
| 508,592 (1) | | |
| $1.30
(2) | | |
| $661,169.60 | | |
| 0.00013810 | | |
| $91.31 | | |
| | | |
| | | |
| | | |
| | |
| | | |
Total
Offering Amounts | | |
| | | |
| $661,169.60 | | |
| | |
| | $91.31 | | |
| | | |
| | | |
| | | |
| | |
| | | |
Total
Fees Previously Paid | | |
| | | |
| | | |
| | | |
| — | | |
| | | |
| | | |
| | | |
| | |
| | | |
Total
Fee Offsets | | |
| | | |
| | | |
| | | |
| — | | |
| | | |
| | | |
| | | |
| | |
| | | |
Net
Fees Due | | |
| | | |
| | | |
| | | |
| $91.31 | |
| | | |
| | | |
| | | |
| | |
|
| (1) |
Represents
shares of common stock to be sold by the selling securityholders. Pursuant to Rule 416 under the Securities Act of 1933, as amended
(the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock
as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar
transactions. |
| (2) |
Calculated
pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sale prices for our
common stock as reported by the NASDAQ Capital Market on November 14, 2025. |
N/A